Product
Reference Medicinal Product
1 clinical trial
1 indication
Indication
Rheumatoid ArthritisClinical trial
A Single Dose, Double-Blind, Parallel Arm, Comparative Pharmacokinetic Study of DRL_AB, US Licensed Reference Abatacept (Orencia®) and EU Approved Reference (Orencia®), Administered by the Subcutaneous Route to Male Normal Healthy VolunteersStatus: Recruiting, Estimated PCD: 2024-04-01